{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:22:47Z","timestamp":1774794167184,"version":"3.50.1"},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/fpc.0000000000000071","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T14:35:36Z","timestamp":1403620536000},"page":"401-405","source":"Crossref","is-referenced-by-count":41,"title":["Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis"],"prefix":"10.1097","volume":"24","author":[{"given":"Christian","family":"Enevold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Baslund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah L.","family":"Josephsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik","family":"Tarp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-4-20210213","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/db08-0968","article-title":"Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women.","volume":"58","author":"Qi","year":"2009","journal-title":"Diabetes"},{"key":"R5-4-20210213","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","article-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health OrganizationInternational League Against Rheumatism Cri.","volume":"39","author":"Van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R7-4-20210213","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:22:11Z","timestamp":1620951731000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201408000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000071","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}